Supplemental material
Human Vaccines & Immunotherapeutics
Volume 14, 2018 - Issue 7
Research Paper
Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection
, , , , , 
, , & show all
George N. PavlakisHuman Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, UShttp://orcid.org/0000-0002-4027-4036
http://orcid.org/0000-0002-4027-4036, Barbara K. FelberHuman Retrovirus Pathogenesis Section and Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, UShttp://orcid.org/0000-0001-8925-8128
http://orcid.org/0000-0001-8925-8128, & show allRelated Research Data
Long-Lasting Decrease in Viremia in Macaques Chronically Infected with Simian Immunodeficiency Virus SIVmac251 after Therapeutic DNA Immunization
Source:
American Society for Microbiology
The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens.
Source:
Elsevier BV
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
Source:
Oxford University Press (OUP)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Source:
Springer Science and Business Media LLC
Structural and Functional Constraints Limit Options for Cytotoxic T-Lymphocyte Escape in the Immunodominant HLA-B27-Restricted Epitope in Human Immunodeficiency Virus Type 1 Capsid
Source:
American Society for Microbiology
Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.
Source:
American Society for Microbiology
Phenotypic and Functional Profile of HIV-Inhibitory CD8 T Cells Elicited by Natural Infection and Heterologous Prime/Boost Vaccination
Source:
American Society for Microbiology
Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption
Source:
Proceedings of the National Academy of Sciences
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.
Source:
Proceedings of the National Academy of Sciences
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Source:
Springer Science and Business Media LLC
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines
Source:
Springer Science and Business Media LLC
Control of Viremia and Prevention of AIDS following Immunotherapy of SIV-Infected Macaques with Peptide-Pulsed Blood
Source:
Public Library of Science (PLoS)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells
Source:
American Society of Hematology
Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag.
Source:
Elsevier BV
Potent, Persistent Induction and Modulation of Cellular Immune Responses in Rhesus Macaques Primed with Ad5hr-Simian Immunodeficiency Virus (SIV) env/rev, gag, and/or nef Vaccines and Boosted with SIV gp120
Source:
American Society for Microbiology
Updated Studies on the Development of HIV Therapeutic Vaccine
Source:
Bentham Science Publishers Ltd.
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.
Source:
Springer Science and Business Media LLC
Virus-Specific CD8+ T-Cell Responses Better Define HIV Disease Progression than HLA Genotype
Source:
American Society for Microbiology
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.
Source:
Elsevier BV
HIV-1 group M conserved elements vaccine.
Source:
Public Library of Science (PLoS)
Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication
Source:
American Society for Microbiology
A High Viral Burden Predicts the Loss of CD8 T-Cell Responses Specific for Subdominant Gag Epitopes during Chronic Human Immunodeficiency Virus Infection
Source:
American Society for Microbiology
Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles
Source:
American Society for Microbiology
HIV-1 p24gag Derived Conserved Element DNA Vaccine Increases the Breadth of Immune Response in Mice
Source:
Public Library of Science (PLoS)
Conserved HIV-1 Epitopes Continuously Elicit Subdominant Cytotoxic T-Lymphocyte Responses
Source:
Oxford University Press (OUP)
HIV therapeutic vaccines: moving towards a functional cure.
Source:
Elsevier BV
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Source:
Springer Science and Business Media LLC
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes.
Source:
Springer Science and Business Media LLC
Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.
Source:
Public Library of Science (PLoS)
Portable flanking sequences modulate CTL epitope processing
Source:
American Society for Clinical Investigation
Linking provided by
